flow obviously increased again to 81 ± 31 PU (P < 0.05). BE was -6 ± 4 mmol/L, which was significantly different compared to Group 1 (P < 0.05). Furthermore, histology revealed less extensive edema and necrosis in pancreatic tissue in Group 3 than that in Group 1. CONCLUSION: AP caused dramatic microcirculatory changes within the pancreas, with development of metabolic acidosis and tissue necrosis. EA allowed partial restoration of microcirculatory flow and prevented development of tissue necrosis and systemic complications. Therefore, EA should be considered as therapeutic option to prevent evolution from edematous to necrotic AP.
INTRODUCTION
Among patients suffering from acute pancreatitis (AP), 80% have a favorable evolution and approximately 20% develop a severe disease with significant morbidity and mortality [1] . Severe AP is associated with the development of local complications, such as pancreatic and peripancreatic necrosis, abscesses or pseudocysts, and systemic complications, such as adult respiratory distress syndrome or renal failure with a mortality close to 15% [2] .
The pathophysiology of AP is incompletely understood but alteration in the pancreatic microcirculatory blood flow has been involved. Thus, a decrease in pancreatic blood flow occurs early in the course of AP and has been sug gested to play a role in the conversion of edematous to necrotizing AP [3] [4] [5] [6] [7] . The microcirculatory dysfunction includes arterial vasoconstriction with hypoperfusion, ischemia-re perfusion injur y, and obstruction of the venous outflow [8] [9] [10] [11] . Other factors that participate in the development of microcirculatory dysfunction are hemoconcentration, hypercoagulability, and increase in microvascular permeability [8] [9] [10] [11] . Besides perfusion abnormalities, AP is also characterized by local and systemic inflammatory responses, including leukocyte activation as well as release of free radicals and cytokines [12] [13] [14] .
Many therapeutic agents, such as dextran, heparin, p r o c a i n e, L -a r g i n i n e, a n t i ox i d a n t s, o r c y t o k i n e antagonists, have been tested experimentally and/or clinically to improve pancreatic tissue perfusion during AP, however, no significantly successful result has been achieved [1, 4, [15] [16] [17] [18] .
Epidural anesthesia (EA) that is used to induce analgesia in the perioperative period might be an interesting treatment of the microcirculatory blood flow abnormalities. Thus, EA can reduce the incidence of post-operative pulmonary complications, and shorten the duration of the post-operative intestinal paralysis [19, 20] . In addition, experimental studies have shown that EA increases gut mucosal blood flow and delays the metabolic acidosis due to intestinal ischemia in the presence of a decreased perfusion pressure [21] [22] . The beneficial effect of EA has been attributed to a sympathetic nerve blockade, which redistributes blood flow to the non-perfused regions of the gut [21] . Additionally, EA is useful to decrease pain in patients with AP [23] , but no study has investigated the effects of EA on the pancreatic microcirculatory blood flow during AP.
Because we postulated that EA might improve the pancreatic hypoperfusion induced by AP and concomitantly decrease the severity of the disease, we measured the pancreatic microcirculatory blood flow and the severity of the disease in rats injected with taurocholic acid in the biliopancreatic duct, in the presence or in the absence of EA.
MATERIALS AND METHODS

Animals
Adult male Wistar rats (275-300 g) were provided by Charles River (L'Arbresle, France). Animals were bred and housed in standard cages and maintained in climatecontrolled rooms. Animals were fed with standard laboratory chow, given water ad libitum, and randomly assigned to control or treated groups. The protocol was approved by the Animal Ethical Committee of the Geneva University Medical School and by the Geneva Veterinary Authorities.
Epidural anaesthesia
Epidural catheters were placed in rats under isoflurane anesthesia. A polyethylene catheter (PE10, Portex, Kent, UK) was introduced in the lumbar region and positioned into the epidural region between T7 and T9 according to the technique previously described by Grouls et al [24] . The external end of the catheter was tunneled subcutaneously and fixed to the occiput.
The animals were allowed to recover from anesthesia and 1 h after epidural catheterization, bupivacaine (4 g/L, 20 µL) was injected to test anaesthesia. Hind limb muscle tone was scored by manual inspection and visual observation as previously described during 30 min [21, 24] . A normal tone with free movement of the hind limbs was scored 0; weak hypotonia of the hind limbs and of the body was scored 1; moderate hypotonia of the hind limbs and of the body was scored 2; and inability to support the body on the hind limbs and flat body posture was scored 3. After scoring, rats were allowed to recover for 2 h. Animals showing signs of neurologic damage were discarded. To verify the position of the catheter, after rat sacrifice, Evans blue solution was injected in the catheter and the spinal column exposed. Animals that had the catheter tip located intrathecally or outside the region between T7 -T9 were excluded from the study.
Surgical preparation
Anaesthesia was induced by pentobarbital sodium (50 mg/kg intraperitoneally) and isoflurane inhalation. Rats had tracheotomy under isoflurane anesthesia and were mechanically ventilated (Harvard apparatus, model 683, South Natick, MA) with a Fio2 = 0.5. The left femoral vein was cannulated and continuously perfused with saline solution (2.5 mL/100 g/h). The left femoral artery was cannulated for continuous monitoring of arterial blood pressure and blood gas analysis (ABL 505 Analyzer, Radiometer, Copenhagen, Denmark). Body temperature was kept constant with a warm pad.
Blood samples were harvested every 30 min for blood gas analysis and ventilation was adjusted to obtain pCO2 between 35 and 45 mmHg. The blood samples were also analyzed for serum amylase concentrations using 4,6-ethylidene (G1)-p-nitrophenyl (G1)-αaD-maltoheptoside (Sigma Chemical Co, Zurich, Switzerland) as substrate. Mean arterial pressure was continuously recorded and stored via an analog-digital interface converter (Biopac, Santa Barbara, CA) on an AST microcomputer (AST, Limerick, Ireland).
Induction of acute pancreatitis
After laparotomy, the pancreatic duct was cannulated with a 22-gauge catheter (Abott, Sligo, Ireland) [25] . A clip was placed on the pancreatic duct close to the liver and taurocholic acid (5%, 500 µL, Sigma, Saint-Louis, MO) was infused over 4 min with a micropump [25] .
Pancreatic microcirculatory blood flow
Pancreatic microcirculatory blood flow was measured with a laser Doppler flowmetry (Periflux system 5000, Perimed AB, Järfälla, Sweden). To position the probe, a latex adhesive probe miniholder (model PH07, Perimed, Järfälla, Sweden) and a special articulated laboratory stand were used. The Doppler probe was placed under the pancreatic surface with the light directed upward. After a 10 to 15 min stabilization period, the effect of AP and/or EA on the pancreatic microcirculatory blood flow was measured over time. The pancreatic microcirculatory blood flow was continuously recorded and stored via an analogdigital interface converter (Biopac, Santa Barbara, CA) on an AST microcomputer (AST, Limerick, Ireland). modification did not reach statistical significance (P = 0.7, Figure 2 ). In Group 3, induction of AP caused a similar decrease in pancreatic microcirculatory flow as in Group 1, i.e., from 155 ± 25 units to 11 ± 7 units (93%, P = 0.004). After induction of EA, mean pancreatic microcirculatory blood flow increased again significantly to 81 ± 31 units within 45 min, reaching 52% of baseline values (P = 0.028, Figures 2 and 3) . 
Figure 2
Pancreatic microcirculatory blood flow (arbitrary units). In Group 1, the mean value of pancreatic blood flow measured prior to and after induction of AP showed a significant decrease of perfusion from 141 ± 40 units to 9 ± 6 units (96%) ( 1 P = 0.008) within 30 min. In Group 2, the mean value of pancreatic blood flow measured prior to and after induction of epidural anaesthesia showed no significant modification of perfusion. In Group 3, mean value of pancreatic blood flow measured prior to and after induction of AP, and epidural anaesthesia, respectively. Induction of AP caused a significant decrease in pancreatic microcirculatory flow from 155 ± 25 units to 11 ± 7 units (93%) ( 2 P = 0.004). After induction of epidural anesthesia, mean pancreatic microcirculatory blood flow increased again significantly to 81 ± 31 units within 45 min, reaching 52% of base line values ( 3 P = 0.028). and cut into 5-µm thick sections. After staining with hematoxylin-eosin, the sections were examined by two experienced morphologists who were not aware of the sample identity. The extent of acinar cell necrosis was quantified by computer assisted morphometry as previously described [26] and expressed as a percent of total acinar tissue.
Experimental design
Three experimental groups were studied (Figure 1 ). In Group 1 (n = 9), rats had AP induction and no EA. Pancreatic microcirculatory blood flow was measured before taurocholic acid injection and continued after the induction of AP. In Group 2 (n = 4), the pancreatic microcirculatory blood flow was determined before and continued after the induction of EA. In Group 3 (n = 6), 30 min after taurocholic acid injection, bupivacaine was injected via the epidural catheter and the pancreatic microcirculatory blood flow measured over time.
Statistical analysis
Results were expressed as mean ± SD. Nonparametric Wilcoxon Signed ranks test and Kruskal-Walis tests for comparison between groups were used as appropriate. P<0.05 was considered statistically significant.
RESULTS
Epidural anesthesia in rats
EA was tested by bupivacaine injection in Groups 2 and 3. In all rats, hind limb blockade was complete within 2 min and the motility completely recovered within 25-30 min after the injection. In Group 3, rats had taurocholic acid injection to induce AP and were treated with bupivacaine ( Figure 1 ).
Pancreatic microcirculatory blood flow
In Group 1, induction of AP caused a significant decrease of mean pancreatic microcirculatory blood flow from 141 ± 40 units to 9 ± 6 units (96%, P = 0.008) within 30 min ( Figure 2 ). The decreased blood flow remained unchanged until the end of the experiment. In Group 2, EA slightly increased microcirculatory blood flow, but the Figure 6B ). In Group 3, edema and necrosis were less extensive compared to animals in Group 1 ( Figure 6D ). The extent of acinar cell necrosis measured as percentage of total surface at high power field (HPF) showed that Group 2 animals had similar cell necrosis as the controls (<10%) (Figure7). Group 1 animals demonstrated over 40% of acinar cell necrosis at HPF, whereas acinar cell necrosis was below 30% in Group 3 animals ( Figure 7 ). [3, 7, 16, 25] . The decrease was -96% within 15 min and pancreatic microcirculatory blood flow remained low until the end of the experiment. The microcirculatory blood flow has been accurately measured by laser Doppler flowmetry. The technique is ideal for monitoring changes in tissue perfusion over time and has successfully been applied to numerous organs in experimental and human studies [4, 6, 24, 27] . However, several factors, such as artifacts induced by respiration, external light exposure and temperature, can affect the interpretation of the laser Doppler signals [4] . In addition, microcirculatory flow can vary widely over short distances, and small changes in probe angle during measurement can alter the measured values. To prevent these technical problems, we used a new type of probe holder, which allows the tissue to be maintained by gravity, avoiding repeated repositioning of the probe.
DISCUSSION
I n o u r s t u d y, t a u r o c h o l i c a c i d i n j e c t i o n i n t h e biliopancreatic duct induced a pancreatic hypoperfusion as reported by previous studies
More importantly, we showed that after induction of AP, bupivacaine injection in the epidural catheter increased pancreatic microcirculatory blood flow. Concomitantly, the improved microcirculatory blood flow within the pancreas decreased the severity of AP. Serum amylase Figure 5 Serum amylase levels. In Group 1, serum amylase levels increased from 694 ± units/L 419 prior to AP to 2178 ± 561 units/L ( 1 P < 0.05, vs serum amylase levels before induction of AP) after 2 h of induction of AP. In Group 2, epidural anaesthesia did not modify serum amylase levels significantly (P = 0.9). In Group 3, serum amylase levels increased to a maximum of 1829±641 units/L after 2 h of initiation of AP and epidural anesthesia. Although this result was lower compared to Group 1, but did not reach statistical significance ( 3 P = 0.08). 
Arterial blood gas and serum amylase analyses
In Group 1, severe metabolic acidosis developed progressively reaching a maximum base excess (BE) value of -14 ± 3 mmol / L at the end of the experiment ( Figure  4) . In Group 2, BE values remained unchanged compared to the baseline values during experiment (Figure 4 ). In Group 3, a mild metabolic acidosis developed reaching a maximum BE value of -6 ± 4 mmol/L at the end of the experiment (Figure 4 ). This result was significantly improved compared to Group 1 (P = 0.007).
In Group 1, serum amylase levels increased from 694 ± 419 units/L prior to AP to 2178 ± 561 units/L (P < 0.05) after 2 h of induction of AP ( Figure 5 ). In Group 2, EA did not modify serum amylase level significantly during the experiment. In Group 3, serum amylase levels increased to a maximum of 1829 ± 641 units/L 2 h after initiation of AP and EA ( Figure 5 ). Although this result was lower compared to Group 1, but did not reach statistical significance.
Histopathology
In Group 1, histopathology revealed a severe form of AP with extensive edema and tissue necrosis ( Figure 6C) . In concentrations and metabolic acidosis were less severe and the histopathologic scores were improved in comparison to rats with AP and no treatment. These results emphasize the importance of a decreased microcirculatory blood flow in inducing severe AP.
To our best of knowledge, this is the first experimental study showing the beneficial effects of EA on the severity of AP. Previous reports already showed that EA increased splanchnic venous capacitance and decreased arterial tone by blocking sympathetic nerve activity [21, 22, [28] [29] [30] . It was also reported that EA might increase sympathetic activity and vasoconstriction in organs distant from the anesthetized area and redistributes blood flow towards splanchnic organs [21] .
It has been postulated that several factors, such as local metabolic acidosis which activates various proteases, oxygen-free radical that injures endothelium and parenchyma, or the incapacity of plasma protease inhibitors to circulate through acinar cells, participate in the modifications of pancreatic microcirculation during AP [3] . These modifications result in diminished intravascular volume, chemically-induced vasoconstriction, intravascular coagulation, and increased endothelial permeability [31] . Finally, pancreatic ischemia, as a consequence of all these local effects, may convert a mild disease to a severe AP with parenchymal necrosis [31] . This has been demonstrated by Klar et al [5] who have shown in anesthetized rabbits that pancreatic blood flow increases when AP is edematous (cerulein injection), whereas pancreatic blood flow decreases when AP is severe (necrotizing form induced by taurocholate injection).
I n o u r s t u d y, E A d e c r e a s e d s e r u m a m y l a s e concentrations, metabolic acidosis, and the severity of pancreatic necrosis score in comparison to rats that had similar taurocholic acid injection and no treatment. Similar benefit of peridural anaesthesia has been shown on metabolic acidosis during hypoxia in dogs [29] .
In conclusion, the current study has shown that EA improves the pancreatic hypoperfusion induced by AP with a concomitant decrease in the severity of metabolic acidosis and a diminished tissue injur y. EA should therefore be considered a new therapeutic approach to prevent the progression from an edematous disease to a necrotizing AP. 
Figure 7
Acinar cell necrosis (percentage of total pancreatic surface). The measure of acinar cell necrosis by percentage of total surface at high power field (HPF) showed that Group 2 animals had similar cell necrosis as the controls (<10%). Group 1 animals demonstrated over 40% acinar cell necrosis at HPF, whereas acinar cell necrosis was below 30% in Group 3 animals. 
